Safety of conversion from cyclosporine Sandimmune to cyclosporine Neoral in stable liver transplant patients.
作者信息
Baruch Y, Assy N, Kramsky R, Enat R
机构信息
Liver Unit, Rambam Medical Center, Haifa, Israel.
出版信息
Transplant Proc. 1998 Aug;30(5):1852-3. doi: 10.1016/s0041-1345(98)00455-2.
PMID:9723306
Abstract
摘要
相似文献
1
Safety of conversion from cyclosporine Sandimmune to cyclosporine Neoral in stable liver transplant patients.稳定期肝移植患者从环孢素（山地明）转换为环孢素（新山地明）的安全性。
Transplant Proc. 1998 Aug;30(5):1852-3. doi: 10.1016/s0041-1345(98)00455-2.
2
Conversion from the conventional cyclosporine formulation (Sandimmune) to a new oral microemulsion (Neoral) in stable liver transplant patients.稳定期肝移植患者从传统环孢素制剂（山地明）转换为新型口服微乳剂（新山地明）的情况。
Transplant Proc. 1998 Aug;30(5):1857. doi: 10.1016/s0041-1345(98)00458-8.
3
Results of conversion from Sandimmune to Neoral in stable pediatric liver transplant recipients after two years.稳定的小儿肝移植受者在两年后从山地明转换为新山地明的结果。
Transplant Proc. 1998 Aug;30(5):1962-3. doi: 10.1016/s0041-1345(98)00496-5.
4
Conversion from Sandimmune to Neoral in stable liver graft recipients.
Transplant Proc. 1996 Aug;28(4):2244-6.
5
Reduced acute rejection after liver transplantation with Neoral-based double immunosuppression.采用以新山地明为基础的双重免疫抑制方案后肝移植急性排斥反应减少。
Transplant Proc. 1998 Aug;30(5):1855-6. doi: 10.1016/s0041-1345(98)00457-6.
6
Case study: conversion of a liver transplant patient from cyclosporine Sandimmune to Neoral.病例研究：一名肝移植患者从环孢素山地明转换为新山地明。
Transplant Proc. 1996 Aug;28(4):2252-3.
7
Conversion from Sandimmune to Neoral in renal transplant recipients: two-year experience.肾移植受者从山地明转换为新山地明：两年经验
Transplant Proc. 1998 Aug;30(5):1753-5. doi: 10.1016/s0041-1345(98)00416-3.
8
Conversion from once-daily Sandimmune cyclosporine to once-daily Neoral in renal transplant patients.肾移植患者从每日一次的山地明环孢素转换为每日一次的新山地明。
Transplant Proc. 2000 Nov;32(7):1681-2. doi: 10.1016/s0041-1345(00)01417-2.
9
Improvement in correlation between oral dose of cyclosporine and cyclosporinemia after substitution of conventional cyclosporine by Neoral cyclosporine in 296 liver transplant patients.在296例肝移植患者中，将传统环孢素替换为新山地明环孢素后，口服环孢素剂量与环孢素血药浓度之间的相关性得到改善。
Transplant Proc. 1998 Aug;30(5):1833-7. doi: 10.1016/s0041-1345(98)00449-7.
10
Favourable clinical results of Sandimmun-Neoral in malabsorbing liver and heart transplant recipients.山地明-新山地明在肝移植和心脏移植吸收不良受者中的良好临床效果。
Transplant Proc. 1994 Oct;26(5):2988-93.
引用本文的文献
1
Cyclosporin: an updated review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (neoral)1 in organ transplantation.环孢素：基于微乳剂的制剂（新山地明）在器官移植中药物动力学特性、临床疗效及耐受性的最新综述
Drugs. 2001;61(13):1957-2016. doi: 10.2165/00003495-200161130-00006.
Zotero 插件